share_log

Jin Medical International Received Letter From Nasdaq Informing The Company That It Regained Compliance With Filing Requirement In Listing Rule 5250(C) Regarding Filing Of Annual Report

Benzinga ·  May 14 16:26
Jin Medical International Received Letter From Nasdaq Informing The Company That It Regained Compliance With Filing Requirement In Listing Rule 5250(C) Regarding Filing Of Annual Report
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment